Resistentia Pharmaceuticals AB
🇸🇪Sweden
Clinical Trials
2
Active:1
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Safety Study of Anti-IgE Immunotherapy in Allergic Patients
Phase 2
Completed
- Conditions
- Allergy
- First Posted Date
- 2007-02-23
- Last Posted Date
- 2008-08-18
- Lead Sponsor
- Resistentia Pharmaceuticals AB
- Target Recruit Count
- 42
- Registration Number
- NCT00439621
- Locations
- 🇳🇿
P3 Research, Wellington, New Zealand
News
No news found